Insulet (PODD)
(Real Time Quote from BATS)
$166.26 USD
+2.09 (1.27%)
Updated Apr 26, 2024 02:04 PM ET
3-Hold of 5 3
D Value A Growth C Momentum B VGM
Brokerage Reports
0 items in cart
Insulet Corporation [PODD]
Reports for Purchase
Showing records 281 - 300 ( 340 total )
Company: Insulet Corporation
Industry: Medical - Products
Presents another hell week for medical device analysts.
Provider: CAPSTONE INVESTMENTS
Analyst: PUTNAM J
Company: Insulet Corporation
Industry: Medical - Products
Company: Insulet Corporation
Industry: Medical - Products
GAUGES IMPACT OF OBAMACARE TAX ON MEDICAL DEVICES COS.
Provider: CAPSTONE INVESTMENTS
Analyst: PUTNAM J
Company: Insulet Corporation
Industry: Medical - Products
PODD Q2 2012: slight miss, FDA clarity gained, raising PT to $24.00
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: Insulet Corporation
Industry: Medical - Products
BUY- FDA GEN2 PUMP APPROVAL DELAYED - Q2 REVS. VERY STRONG
Provider: CAPSTONE INVESTMENTS
Analyst: PUTNAM J
Company: Insulet Corporation
Industry: Medical - Products
PODD Feltl Insulin Pump Project: Historical survey of 2,500+ pump users (2007 present)
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: Insulet Corporation
Industry: Medical - Products
Termination of Coverage
Provider: RODMAN & RENSHAW, CO.
Company: Insulet Corporation
Industry: Medical - Products
Company: Insulet Corporation
Industry: Medical - Products
Medical Devices: Pending Legislation Will Increase FDA''s Reach Offset By Some Benefits
Provider: CAPSTONE INVESTMENTS
Analyst: PUTNAM J
Company: Insulet Corporation
Industry: Medical - Products
In-line quarter...All eyes on regulatory clearance of next-gen Omnipod...
Provider: RODMAN & RENSHAW, CO.
Analyst: KALIA S
Company: Insulet Corporation
Industry: Medical - Products
Company: Insulet Corporation
Industry: Medical - Products
PODD Q1 2012 sales inline; not skittish on next generation OmniPod approval
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: Insulet Corporation
Industry: Medical - Products
In-line quarter... All eyes on regulatory clearance of next-gen Omnipod...
Provider: RODMAN & RENSHAW, CO.
Analyst: KALIA S
Company: Insulet Corporation
Industry: Medical - Products
PODD Feltl Insulin Pump Project: Historical survey of 2,300+ pump users (2007 present)
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: Insulet Corporation
Industry: Medical - Products
Upgrading the stock based on valuation + upcoming clearance of next-gen OmniPod
Provider: RODMAN & RENSHAW, CO.
Analyst: KALIA S
Company: Insulet Corporation
Industry: Medical - Products
Upgrading the stock based on valuation + upcoming clearance of next-gen OmniPodÂ…..
Provider: RODMAN & RENSHAW, CO.
Analyst: KALIA S
Company: Insulet Corporation
Industry: Medical - Products
PODD Respectable Q4, better than expected 2012 revenue guidance, raising PT
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: Insulet Corporation
Industry: Medical - Products
In-line quarter...Super-high expectations with next-gen OmniPod...
Provider: RODMAN & RENSHAW, CO.
Analyst: KALIA S
Company: Insulet Corporation
Industry: Medical - Products
In-line quarter...Super-high expectations with next-gen OmniPod...
Provider: RODMAN & RENSHAW, CO.
Analyst: KALIA S
Company: Insulet Corporation
Industry: Medical - Products
Q4 REVENUES ON-TRACK-LOSS SLIGHTLY HIGHER BUT OF LITTLE CONCERN-BUY
Provider: CAPSTONE INVESTMENTS
Analyst: PUTNAM J